top of page

Events

Conferences & Exhibitions

We regularly exhibit and present at conferences and exhibitions where you have the opportunity to see our Coflore Flow Reactors in person and speak to our team of experts. This page is regularly updated so please check back for further updates.

CPHI Guangzhou

Date: 4 - 6 September, 2023

Location: Guangzhou, China

Event Details: https://www.cphi-china.cn/guangzhou/

AM Technology's Business Development Manager, Dr Mike Kenny, is attending the event with our distributor E-Zheng. If you want to discuss your application with Mike, please fill in our contact form here.

1670925770714_edited.png

Flow Chemistry India

Date: 14 - 15 September, 2023

Location: Mumbia, India

Event Details: https://www.glostem.in/events/?conf=FCI23

AM Technology's Senior Flow Chemist, Martin Monedero, is presenting our latest work at this event. Our Business Development Manager, Mike, and Technical Sales Engineer, Nicholas, will be in attendance. 

393Website Banners FCI23.jpg

Drug Discovery 2023

Date: 18 - 19 October, 2023

Location: Liverpool, UK

Event Details: https://www.elrig.org/portfolio/drug-discovery-2023/

If you want to discuss your flow chemistry requirements and see the Coflore reactor range in person, head to our stand!

Screenshot 2023-08-17 at 15.32.49.png

Automated Synthesis Forum

Date: 27 - 28 November, 2023

Location: Novartis Campus, Basel, Switzerland

Event Details: https://automatedsynthesisforum.co.uk/

Further details for this event will be announced soon. 

cropped-banner-e1551179807206.webp

CHEMUK 2024

Date: 14 - 16 May, 2024

Location: NEC, Birmingham, UK

Event Details: https://www.chemicalukexpo.com/

Screenshot 2023-08-17 at 15.21.21.png

Bristol Synthesis Meeting

Date: 9 April, 2024

Location: University of Bristol, South UK

Event Details: https://www.bristol.ac.uk/chemistry/research/bristol-synthesis-meeting/

Slide1.jpeg

“One of today's most important tools for modernizing the pharmaceutical industry is a process known as continuous manufacturing”

Director of the FDA’s Centre for Drug Evaluation and Research,

bottom of page